Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

dutasteride

5mg, oral, daily, 2-4 weeks

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Korean Urological Association

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Seoul National University Hospital

OTHER